Clinical trial Recruiting at 1 site Interventional Ages 12 to 17

Treatment for social anxiety in adolescents using cognitive therapy

Official title: School-based Treatment of Social Anxiety: A Randomized and Controlled Study Using Developmentally Oriented Cognitive Therapy for Social Anxiety Disorder

Run by Tampere University · NCT06489639 · Data updated 2026-11-12

This study is testing if a new 10-session therapy for social anxiety can help teenagers feel better compared to regular counseling.

Quick facts

Study typeInterventional
Ages12 Years to 17 Years
SexAll
Enrollment156 (estimated)
SponsorTampere University
Academic / other
Locations1 site (Tampere, Pirkanmaa)
StatusRecruiting
StartedMarch 20, 2023
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedJuly 8, 2024
Trial IDNCT06489639 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adolescents aged 12 to 17 with a primary diagnosis of Social Anxiety Disorder as per DSM-5 criteria.

Probably not a fit

Patients with intellectual deficits, autism spectrum disorders, or other severe mental health issues requiring immediate treatment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the effectiveness of a brief, 10-session Developmentally Oriented Cognitive Therapy for Social Anxiety Disorder (DOCT-SAD) against standard counseling (SC) for adolescents aged 12 to 17 diagnosed with Social Anxiety Disorder (SAD). Participants will be recruited from public secondary and vocational schools in the Tampere area of Finland, where trained school psychologists will deliver the DOCT-SAD intervention. The study will assess whether DOCT-SAD can better alleviate symptoms of social anxiety and lead to diagnostic remission compared to SC provided by non-method-trained professionals. A total of 156 students will be involved in this randomized controlled trial.

Why it matters

Potential benefit: If successful, this treatment could significantly improve the mental health and social functioning of adolescents suffering from social anxiety.

How similar studies have gone: Previous studies have shown promising results for cognitive therapy approaches in treating social anxiety, suggesting potential success for this intervention.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* age 13-17 years
* diagnosis of DSM-5 SAD (Social Anxiety Disorder)
* SAD is the primary mental health disorder
* motivation of the adolescent and parent to attend DOCT-SAD / SC as described in the study protocol
* good command of the Finnish language.

Exclusion criteria:

* intellectual deficit
* presence of primary autism spectrum disorder
* marked psychotic symptoms or psyhotic disorder
* severe eating disorder, depression or primary other anxiety disorder requiring acute treatment which need to be prioritized above treatment of social anxiety
* acute suicidality or suicide risk
* substance use or substance use disorder requiring child protection measures
* presence of contextual/environmental risk factors in the participants surroundings which require child protection measures

Where it's running

  • Tampere University
    Tampere, Pirkanmaa, Finland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.